Cervical Cancer Screening ICC Immunoassay Test Kit Cap Asccp p16 / Ki-67 CE

KISSH P16/Ki-67 Dual Staining Reagent

Cervical Cancer Screening ICC Immunoassay Cap Asccp p16 / Ki-67 CE

Product Introduction

p16/Ki-67 dual staining reagent is an important marker for cervical cancer screening and diagnosis, which is a new detection method joint recommended by CAP and ASCCP, also recommended by Bethesda Version 2015.

Intended Use

Higher Sensitivity

• Bypassed with higher sensitivity and specificity
• Specificity much high than HR-HPV detection

Specification

• 25 tests/kit ,50 tests/kit ,100 tests/kit

Shenzhen Kisshealh Biotechnology Co., Ltd., located in the Pingshan District, Shenzhen, P.R. China. is a diagnostics company focused on the development and manufacture of IVD tests at the Point-of-Care with highly innovative proprietary technology.

We focused on the emerging markets of in vitro pathological diagnosis and immunodiagnosis. We developed, manufactured and successfully launched the in vitro immunodiagnosis platform for cancer and the POCT for infectious, genetic and chronic diseases.

<span style="color: rgb(33, 33, 33); text-transform: none; text-indent: 0px; letter-spacing: normal;" initial;"="" initial;="" 0px;="" normal;="" 255);="" 255,="" rgb(255,="" 2;="" !important;="" inline="" none;="" 600;="" 14px;="" sans-serif;="" arial,="" roboto,="" w3",="" gb="" sans="" "hiragino="" gb",="" hei",="" micro="" "wenquanyi="" sans",="" "droid="" arimo,="" freesans,="" yahei",="" "microsoft="" helvetica,="" grande",="" "lucida="" ui",="" segoe="">At Kissh we work every day to shape the future of in-vitro diagnostic testing. And our people are our best asset, the reason for our track record and our strength while we are moving forward. We live by our fundamental values and incorporate them in everything that we do. Our best asset is ‘Step Forward Every Second’